Unprecedented victory for a Brazilian company at the European Unified Patent Court | Relevant precedent for international protection.

A recent decision by the Unified Patent Court of Europe (UPC) sets an unprecedented precedent for a Brazilian company in a forum that is reshaping patent litigation on the continent. The case stands out not only for its favorable outcome but also for the institutional relevance of the court, created in 2023 to centralize patent disputes with effects in multiple European countries. Instead of the traditional fragmentation among national actions, the UPC now allows for decisions with a broader regional reach, significantly altering the strategy for protecting and defending technological assets abroad.

In this case, the Brazilian company was able to demonstrate that it was the true inventor of the technology applied to the breast implant, obtaining the transfer of ownership of the patent that had been registered by the foreign distributor. Subsequently, it obtained an injunction to halt the manufacture of the product based on this technology, in addition to paving the way for future compensation. The precedent reinforces that, even when the patent application was filed by a third party, it is still possible to legally dispute ownership when there is consistent technical evidence proving the origin of the invention.

The decision is particularly relevant because it demonstrates that technological assets developed in the country can be successfully defended in highly complex foreign jurisdictions, provided they are supported by a consistent patent protection strategy, robust technical documentation, and proper organization of the invention's ownership.

This case reinforces that the protection of innovation is not limited to filing the application, but involves skilled evidence management, traceability of technological development, and a legal structure capable of supporting, at an international level, authorship and exclusivity over the technology.